▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Microvision Q1 22 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 4/27/2022 3:00 PM ET

Microvision Inc. (MVIS) will host a conference call at 5:00 PM ET on April 27, 2022, to discuss Q1 22 earnings results.

To access the live webcast, log on to https://ir.microvision.com/news/ir-calendar/detail/9904/q1-2022-financial-and-operating-results-call

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

18K New Covid Cases, 144 Deaths In US

184K New Covid Cases, 860 Deaths In U.S.

50K New Covid Cases, 80 Deaths In U.S.

Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial

15K New Covid Cases, 36 Deaths In US

Read More

COVID-19: Drugs in Development

RELATED NEWS

Microvision Inc. Q1 Loss increases, misses estimates

Microvision Q1 22 Earnings Conference Call At 5:00 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Creminelli Recalls Mini Parmesan Salami Stick Products

FDA Proposes Rule To Advance Consumer Access To OTC Drugs

US To Get 21 Mln Bottles Of Bellamy's Organic Infant Formula From Australia

Flight Cancellations, Delays On The Rise In US

FSIS Warns Against Ineligible Siluriformes Products Imported From Korea

Panera At Home Southwest Corn Chowder Recalled

MTD Products Recalls Walk-Behind Self-Propelled Lawn Mowers

Nike To Fully Exit Russia As Ukraine Invasion Continues

FDA Action Plan To Speed Up Drug Development For Rare Neurodegenerative Diseases

Loctek Recalls Fleximouts Overhead Garage Storage Racks

FDA Action Plan To Speed Up Drug Development For Rare Neurodegenerative Diseases

NTLA : Study Of NTLA-2001 On Transthyretin Amyloidosis Shows Serum TTR Reductions Remained Durable

Mirum Pharma Presents Data Showing Impact Of LIVMARLI On Patients With Alagille Syndrome

Novartis' Scemblix Gets Positive CHMP Opinion For Treatment Of Chronic Myeloid Leukemia

Kezar Life Sciences Stock Surges 105% On Positive Data Drug Trial Results

Sanofi-GSK Reports Positive Data From COVID-19 Beta-containing Vaccine Trial

Pfizer, BioNTech Report Positive Data From Omicron-adapted COVID-19 Vaccine Candidate Trial

Basilea' Partner Pfizer Gets Approval In China For Addl Formulation Of Antifungal Cresemba In China

Argenx Stock Up On Positive CHMP Opinion For Efgartigimod For GMG Patients In Europe

Gilead: CHMP Adopts Positive Opinion For Lenacapavir To Treat People With Multi-Drug Resistant HIV

Antengene, BeiGene To Evaluate Selinexor Combination In T And NK-Cell Lymphoma

FDA Proposes Rule To Advance Consumer Access To OTC Drugs

Panera At Home Southwest Corn Chowder Recalled

China's Sinovac COVID-19 Vaccine CoronaVac Registered For Use In South Africa

Lamprell Receives Indicative Cash Offer From Blofeld

Jadestone Energy Appoints Bert-Jaap Dijkstra As New CFO

McDonald's Appoints Ian Borden To Succeed Kevin Ozan As CFO

Keller Group Sees Full-year Performance Inline, Bags Order From S.Arabia 's NEOM Giga Project

Occidental Petroleum Up As Warren Buffett Adds Stock

NTLA : Study Of NTLA-2001 On Transthyretin Amyloidosis Shows Serum TTR Reductions Remained Durable

Stagecoach FY Adj. Pretax Profit Rises

Li Auto Says Orders For Newly Launched SUV Li L9 Crossed 30K Mark In 3 Days; Stocks Up In Pre-market

Basilea' Partner Pfizer Gets Approval In China For Addl Formulation Of Antifungal Cresemba In China

Ascletis' ASC22 Shows Potential Of Functional Cure Of Chronic Hepatitis B In Phase IIb Trial